Vendor, Malden, MA
Seco Bio, Inc.
UEI GZ3UDKV32SA9, CAGE 10PL3
1 award and $310,000 obligated between July 30, 2025 and April 2, 2026, 0% under full and open competition, against 44.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $310,000 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Definitive Contract | 1 |
Hear when Seco Bio, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Seco Bio, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $310,000
- Soonest
- December 31, 2026
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Defense Advanced Research Projects Agency, by dollars.
| Bifrost Biosystems Inc.Berkeley, CA | $2,469,502 |
| University of TennesseeKnoxville, TN | $748,000 |
| Council on Strategic Risks (The)Washington, DC | $356,648 |
| Kairu Therapeutics Inc.Alameda, CA | $350,000 |
| Repro-T CompanyArlington, MA | $349,997 |
| Polaris Quantum Biotech Inc.Cary, NC | $300,000 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HR001125CE047Definitive Contract, July 30, 2025, Competed Under SAP, 44 offers | Def Advanced Research Projects AgcyDefense Advanced Research Projects Agency | Embedded Entrepreneur Initiative (Eei)NAICS 541714, PSC B541 | $310,000 |
- Places of performance
- Massachusetts
- Product and service codes
- B541 Defense Studies
- Transactions
- 2 across 1 awards